A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease

2005578 citationsJournal Article

Authors

Good health and well-being

Published in: Gastroenterology

Volume 129, Issue 3, pp. 807-818

Field-Weighted Citation Impact: 32.48